23 news items
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
REGN
16 Jun 24
and is accessible on Regeneron's media and investor relations website
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
REGN
11 Jun 24
. who are prescribed Kevzara gain access to the medicine and receive the support they may need. KevzaraConnect®, a comprehensive
MAIA Biotechnology Inc (MAIA) Stock Surges as Company Prepares to Present Promising Data at BIO International Convention
CRL
IQV
MAIA
31 May 24
not constitute professional and/or financial advice. InvestorBrandMedia.com is not a fiduciary by virtue of any person’s use of or access to this content
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
REGN
31 May 24
and is accessible on Regeneron's media and investor relations website
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
REGN
31 May 24
posted and is accessible on Regeneron's media and investor relations website
uwyolsfdjm7rd591xv kkry1
REGN
31 May 24
information that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible
w7yw3zmvw5 75a6mbzii3
REGN
23 May 24
, including information that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible
kvywl8o54np8y6 62mi01byl5jlmsf4b
REGN
20 May 24
and is accessible on Regeneron's media and investor relations website (https
42pr4vv8588kzly23817akisw50qfzorhixz7y
REGN
20 May 24
. Financial and other information about Regeneron is routinely posted and is accessible on Regeneron's media and investor relations website
519g3tkz3nfte0h226a2m1l7rkncuc0ixxjvf4 mc78asf
REGN
17 May 24
serve as a viable option for dementia patients with limited access to in-person professional therapy
y0hmby1l4mint46b7k0qq2tiws05w9gb46k53ufkosdmjv6i mlul
REGN
17 May 24
as a viable option for dementia patients with limited access to in-person professional therapy
t42z0zu3jufbtfsd60ba 0nukd8j5yai51g
REGN
17 May 24
app could serve as a viable option for dementia patients with limited access to in-person professional therapy
8u3f37v1 2n7fflqvejb4c7p34axcu9e74nimtlct1e7wokbvy0c
REGN
13 May 24
be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible on Regeneron's media
h10ll
REGN
8 May 24
information that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible
07dj8767gni8d0ae g3gm1stu4vu
REGN
6 May 24
, June 11, 2024 The sessions may be accessed from the "Investors & Media" page of Regeneron's website
043 uqh8ya71sgp
REGN
2 May 24
results on Thursday, May 2, 2024, at 8:30 AM Eastern Time. Participants may access the conference call live via webcast, or register in advance
00xppfgu4rjxa6fxx0b y8xhalxnrrtuw992sj
REGN
29 Apr 24
, including information that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible
p0j61qnp6n6dfh4peat5ifit6b26k6gbrrjc3 hrmzp4j9nwei3c
REGN
22 Apr 24
information about Regeneron is routinely posted and is accessible on Regeneron's media and investor relations website
vkmw3iq1t8w48g739a2pio6c6vhdf4r2i3glw6cly
REGN
7 Apr 24
that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible on Regeneron's
5svmng 1fn
REGN
1 Apr 24
may access the conference call live via webcast on the 'Investors and Media' page of Regeneron's website